Simulated client study on the dispensing practices for narcotic and psychotropic medications in community drug outlets in Ethiopia

Tirsit Ketsela Zeleke, Minichil Chanie Worku, Bantayehu Addis Tegegne, Fasil Bayafers Tamene, Gebremariam Wulie Geremew, Samuel Agegnew Wondm, Aschalew Mulatu Tefera, Ayelign Eshete Fitgu, Tekletsadik Tekleslassie Alemayehu, Muluken Adela Alemu, Rahel Belete Abebe, Kale Gubae, Abraham Teym

Article Type

Original Research

Published

This study aimed to assess the extent and factors of non-prescription dispensing of narcotic and psychotropic medications at community drug retail outlets in Ethiopia.

Read more

Anxiety disorders, PTSD and OCD: systematic review of approved psychiatric medications (2008–2024) and pipeline phase III medications

Emile Tadros, Shirley Keerthana, Samar Padder, Jayant Totlani, Drew Hirsch, Daniel N Kaidbay, Lorena Contreras, Aasim Naqvi, Samuel Miles, Krista Mercado, Ashley Meyer, Sabrina Renteria, Robert N Pechnick, Itai Danovitch, Waguih William IsHak

Article Type

Review

Published

By examining the mechanisms of action, indications, efficacy, dosing and adverse effects of psychiatic medications approved by the FDA, this review seeks to evaluate the progress and future directions in the pharmacological treatment of post-traumatic stress disorder and obsessive-compulsive
disorder.

Read more

Lecanemab for mild Alzheimer disease – is there a way forward?

Rajesh R Tampi

Article Type

Editorial

Published

This Editorial reviews data on the efficacy and adverse effects of lecanemab amongst individuals with mild Alzheimer disease. The need for discussions regarding this medication as well as the importance of developing guidelines for use are also highlighted.

Read more

Towards full recovery with lurasidone: effective doses in the treatment of agitation, affective, positive and cognitive symptoms in schizophrenia, and dual psychosis

María Teresa Guarro Carreras, Luis Jiménez Suárez, Laura Lago García, Laura Montes Reula, Adrián Neyra del Rosario, Francisco Acoidan Rodríguez Batista, Miguel Velasco Santos, Juan L Prados-Ojeda, Marina Diaz-Marsà, Manuel Martín-Carrasco, Antonio Cardenas

Article Type

Case Series

Published

This review explores the effectiveness of high doses of lurasidone in managing all schizophrenia symptoms and its role in addressing post-psychotic depression in dual psychosis cases. Additionally, it delves into real-world insights on the clinical application of lurasidone.

Read more

Register for alerts

I would like to be contacted by Drugs in Context when new articles are posted.